1. Home
  2. BAFN vs PYXS Comparison

BAFN vs PYXS Comparison

Compare BAFN & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BAFN
  • PYXS
  • Stock Information
  • Founded
  • BAFN 1999
  • PYXS 2018
  • Country
  • BAFN United States
  • PYXS United States
  • Employees
  • BAFN N/A
  • PYXS N/A
  • Industry
  • BAFN Savings Institutions
  • PYXS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BAFN Finance
  • PYXS Health Care
  • Exchange
  • BAFN Nasdaq
  • PYXS Nasdaq
  • Market Cap
  • BAFN 63.2M
  • PYXS 75.0M
  • IPO Year
  • BAFN N/A
  • PYXS 2021
  • Fundamental
  • Price
  • BAFN $11.90
  • PYXS $1.06
  • Analyst Decision
  • BAFN
  • PYXS Strong Buy
  • Analyst Count
  • BAFN 0
  • PYXS 5
  • Target Price
  • BAFN N/A
  • PYXS $9.00
  • AVG Volume (30 Days)
  • BAFN 15.6K
  • PYXS 335.9K
  • Earning Date
  • BAFN 07-29-2025
  • PYXS 08-13-2025
  • Dividend Yield
  • BAFN 2.61%
  • PYXS N/A
  • EPS Growth
  • BAFN 102.38
  • PYXS N/A
  • EPS
  • BAFN 1.90
  • PYXS N/A
  • Revenue
  • BAFN $78,211,000.00
  • PYXS N/A
  • Revenue This Year
  • BAFN N/A
  • PYXS N/A
  • Revenue Next Year
  • BAFN N/A
  • PYXS N/A
  • P/E Ratio
  • BAFN $6.44
  • PYXS N/A
  • Revenue Growth
  • BAFN 0.67
  • PYXS N/A
  • 52 Week Low
  • BAFN $11.90
  • PYXS $0.83
  • 52 Week High
  • BAFN $19.75
  • PYXS $5.39
  • Technical
  • Relative Strength Index (RSI)
  • BAFN 30.39
  • PYXS 41.03
  • Support Level
  • BAFN $12.15
  • PYXS $1.03
  • Resistance Level
  • BAFN $13.60
  • PYXS $1.38
  • Average True Range (ATR)
  • BAFN 0.50
  • PYXS 0.08
  • MACD
  • BAFN -0.26
  • PYXS -0.01
  • Stochastic Oscillator
  • BAFN 0.00
  • PYXS 15.79

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Share on Social Networks: